Integrated Wealth Concepts’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$830K Buy
21,645
+5,595
+35% +$147K ﹤0.01% 1457
2026
Q1
$341K Buy
+16,050
New +$321K ﹤0.01% 1776
2025
Q3
Sell
-42,124
Closed -$488K 2099
2025
Q2
$488K Buy
+42,124
New +$384K ﹤0.01% 1292

Other funds holding TXG

Integrated Wealth Concepts's TXG Position: Q2 2026 in Review

Integrated Wealth Concepts increased its 10x Genomics (TXG) stake by 35% in Q2 2026, buying an estimated $147K and bringing the position to 21,645 shares worth $830K. The position accounts for ﹤0.01% of the portfolio, ranked #1457.

Integrated Wealth Concepts first reported a position in TXG in Q2 2025 and has held it in 3 quarters since. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Integrated Wealth Concepts held 21,645 shares of 10x Genomics worth $830K as of Q2 2026.
  • Integrated Wealth Concepts bought 5,595 10x Genomics shares in Q2 2026, an estimated $147K.
  • 10x Genomics made up ﹤0.01% of Integrated Wealth Concepts's portfolio in Q2 2026, its #1457 holding.
  • Integrated Wealth Concepts first reported a position in 10x Genomics in Q2 2025 and has held it in 3 quarters since.
  • 390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Integrated Wealth Concepts's 13F filing for Q2 2026, filed 12 Aug 2026.